2 most recent filings and news items mentioning SLN. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/SLN/news?limit=20"
Pull SLN filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/daySilence Therapeutics filed an exhibit documenting the 2026 corporate presentation and associated forward-looking statements. This filing provides market participants with the material necessary to assess strategic objectives and future projections.
View filing at SEC.gov →Silence Therapeutics presented Phase 1 follow-up data showing divesiran reduced phlebotomy requirements from 80 procedures to 5 during treatment, with benefits persisting post-dose. Phase 2 results are expected in August 2026, potentially supporting a best-in-class profile for th
View filing at SEC.gov →